Where Will Cara Therapeutics Be in 5 Years? [The Motley Fool]
Cara Therapeutics, Inc. (CARA)
Last cara therapeutics, inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.caratherapeutics.com/investor-relations
Company Research
Source: The Motley Fool
Where Will Cara Therapeutics Be in 5 Years? Keith Speights ( TMFFishBiz Jun 9, 09 at :00PM Cara Therapeutics NASDAQ:CARA But where will Cara Therapeutics be five years from now? It depends in large part on those upcoming results for the biotech's lead candidate, Korsuva. Here are three potential scenarios for what could happen with Cara in the next five years. Image source: Getty Images. Scenario No. : Thriving It's easy to envision a future in which Cara Therapeutics is a successful, up-and-coming biotech in 0. That path would start with positive results later this year from the ongoing phase clinical study Approval in the CKD-aP hemodialysis indication would be a great start for Cara. One Wall Street analyst projects that Korsuva could achieve peak annual sales of more than $70 million in this indication. But the real prize for the company will be achieving success for its oral version of Korsuva in CKD-aP patients who aren't on dialysis. This presents a much greater market for Car
Show less
Read more
Impact Snapshot
Event Time:
CARA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARA alerts
High impacting Cara Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
CARA
News
- Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
CARA
Earnings
- 11/14/24 - Beat
CARA
Sec Filings
- 11/14/24 - Form 10-Q
- 11/6/24 - Form 4
- 10/30/24 - Form SC
- CARA's page on the SEC website